Suh et al. indicted that the activation of PI3K/AKT and PI3K/AKT through leucine-rich repeat and immunoglobulin-like domain 2 contributed to suppress the growth of Hec-1A endometrial cancer cells [48]. The gene discussed is AKT1; the disease is endometrial cancer.